Lifeboat Foundation

According to Klaus Schwab, the founder and executive chair of the World Economic Forum (WEF), the 4-IR follows the first, second, and third Industrial Revolutions—the mechanical, electrical, and digital, respectively. The 4-IR builds on the digital revolution, but Schwab sees the 4-IR as an exponential takeoff and convergence of existing and emerging fields, including Big Data; artificial intelligence; machine learning; quantum computing; and genetics, nanotechnology, and robotics. The consequence is the merging of the physical, digital, and biological worlds. The blurring of these categories ultimately challenges the very ontologies by which we understand ourselves and the world, including “what it means to be human.”

The specific applications that make up the 4-R are too numerous and sundry to treat in full, but they include a ubiquitous internet, the internet of things, the internet of bodies, autonomous vehicles, smart cities, 3D printing, nanotechnology, biotechnology, materials science, energy storage, and more.

While Schwab and the WEF promote a particular vision for the 4-IR, the developments he announces are not his brainchildren, and there is nothing original about his formulations. Transhumanists and Singularitarians (or prophets of the technological singularity), such as Ray Kurzweil and many others, forecasted these and more revolutionary developments,. long before Schwab heralded them. The significance of Schwab and the WEF’s take on the new technological revolution is the attempt to harness it to a particular end, presumably “a fairer, greener future.”

A team of physicists has discovered how DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

SRI Newsletter, a report from IAC2021 Dubaiby Prof. Bernard Foing, SRI President, and.

Paramount important too, space philosophy and humanities are now well recognized and accepted by the space community. The first IAF Congress I attended, 1998 at Melbourne, was dramatically void of philosophy, yet participants already were missing it. I saw many young people at IAC2021, scientists, designers, economists, scholars of various disciplines, including philosophy. And, heartwarming indeed, Space Renaissance had a great enthusiastic welcome. The space people know us (and know me!), many people which I didn’t know personally shook my hand, asked me for comments and short talks, were enthusiast about the Space Renaissance… All of that is for sure due to the big work we made for our recent congress, and of course to the great world-wide influence of our new President, Prof. Bernard Foing. Yet, there is something deeper, in the feeling of this peculiar sub-assembly of humankind, that was looking ahead enough to dedicate their life to human expansion into outer space. The last two years – characterized by the Covid pandemics — have worked hard, to shape and forge space leaders, raising the awareness of the urgency to kick-off the civilian space development. And it is now maybe a general acknowledge that the space philosophers were right, when they were rushing for an acceleration of the enabling technologies, low cost access to space, space tourism, space safety, … The need to get rid of space debris was well present in several speeches, even if only a few dare to target space debris as a huge source of business development, when we’ll start capturing and reusing them.

Simple sponges contain cells that appear to send signals to digestive chambers, a communication system that offer hints about how brains evolved.

Professor Stefan Lorenz Sorgner talks about his new book, ‘We Have Always Been Cyborgs’. Find out more about the book: https://bristoluniversitypress.co.uk/we-have-always-been-cyborgs.

“With an encyclopaedic knowledge of transhumanism and a deep philosophical grounding, especially in Nietzschean thought, Stefan Sorgner tackles some of the most challenging ethical issues currently discussed, including gene editing, digital data collection, and life extension, with uncommon good sense and incisive conclusions. This study is one of the most detailed and comprehensive analyses available today. Highly recommended for anyone interested in transhumanist/posthumanist ideas and in these issues generally.” N. Katherine Hayles, University of California, Los Angeles.

Continue reading “We Have Always Been Cyborgs: Professor Stefan Lorenz Sorgner — John Cabot University” »

For people with motor impairments or physical disabilities, completing daily tasks and house chores can be incredibly challenging. Recent advancements in robotics, such as brain-controlled robotic limbs, have the potential to significantly improve their quality of life.

Researchers at Hebei University of Technology and other institutes in China have developed an innovative system for controlling robotic arms that is based on augmented reality (AR) and a brain-computer interface. This system, presented in a paper published in the Journal of Neural Engineering, could enable the development of bionic or prosthetic arms that are easier for users to control.

“In recent years, with the development of robotic arms, brain science and information decoding technology, brain-controlled robotic arms have attained increasing achievements,” Zhiguo Luo, one of the researchers who carried out the study, told TechXplore. “However, disadvantages like poor flexibility restrict their widespread application. We aim to promote the lightweight and practicality of brain-controlled robotic arms.”

Last year DeepMind’s breakthrough AI system AlphaFold2 was recognised as a solution to the 50-year-old grand challenge of protein folding, capable of predicting the 3D structure of a protein directly from its amino acid sequence to atomic-level accuracy. This has been a watershed moment for computational and AI methods for biology.

Building on this advance, today, I’m thrilled to announce the creation of a new Alphabet company – Isomorphic Labs – a commercial venture with the mission to reimagine the entire drug discovery process from the ground up with an AI-first approach and, ultimately, to model and understand some of the fundamental mechanisms of life.

For over a decade DeepMind has been in the vanguard of advancing the state-of-the-art in AI, often using games as a proving ground for developing general purpose learning systems, like AlphaGo, our program that beat the world champion at the complex game of Go. We are at an exciting moment in history now where these techniques and methods are becoming powerful and sophisticated enough to be applied to real-world problems including scientific discovery itself. One of the most important applications of AI that I can think of is in the field of biological and medical research, and it is an area I have been passionate about addressing for many years. Now the time is right to push this forward at pace, and with the dedicated focus and resources that Isomorphic Labs will bring.

AI tools could speed the process of finding new drugs.

Google parent company Alphabet is launching a new company called Isomorphic Laboratories which will use AI tools for drug discovery. It will build off the protein folding work from DeepMind.

Many people develop Alzheimer’s or other forms of dementia as they get older. However, others remain sharp well into old age, even if their brains show underlying signs of neurodegeneration.

Among these cognitively resilient people, researchers have identified education level and amount of time spent on intellectually stimulating activities as factors that help prevent dementia. A new study by MIT researchers shows that this kind of enrichment appears to activate a gene family called MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline.

The researchers observed this link between MEF2 and cognitive resilience in both humans and mice. The findings suggest that enhancing the activity of MEF2 or its targets might protect against age-related dementia.